bleomycetin has been researched along with Mouth Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Hou, R; Lei, D; Liu, Y; Sun, M; Wang, L; Yan, Z; Yang, Y | 1 |
| Sun, ML; Wang, CM; Wen, YM | 1 |
| Chen, J; Chen, SX; Dai, LN; Feng, Y; Li, XY; Liu, YR; Wang, H; Zhang, P; Zhou, CC | 1 |
| Sun, ML; Wang, CM; Wen, YM; Xie, WH | 1 |
| Hou, J; Huang, H; Tang, H; Wang, M; Wang, Y | 1 |
| Gu, Y; He, Z; Peng, B; Yi, S; Zheng, G | 1 |
| Chou, MY; Tai, KW; Yang, JJ; Yang, LC; Yang, SH | 1 |
| Li, LJ; Sun, ML; Wang, CM; Wang, XY; Wen, YM | 1 |
| Dai, Y; Liu, XJ; Zhen, YS | 1 |
| Chang, YC; Ho, YC; Tai, KW | 1 |
10 other study(ies) available for bleomycetin and Mouth Neoplasms
| Article | Year |
|---|---|
Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Arteriovenous Malformations; Bleomycin; Child; Drug Combinations; Facial Neoplasms; Female; Fibrin Tissue Adhesive; Hemangioma, Cavernous; Humans; Injections, Intralesional; Magnetic Resonance Angiography; Male; Mouth Neoplasms; Sclerosing Solutions; Treatment Outcome; Ultrasonography, Doppler | 2008 |
[Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Topics: Antibiotics, Antineoplastic; Bleomycin; Carbon; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Humans; In Vitro Techniques; Mouth Neoplasms; Nanoparticles | 2010 |
[The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mouth Neoplasms; Salicylates | 2010 |
[Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Topics: Animals; Bleomycin; Carbon; Lymph Nodes; Lymphatic Metastasis; Mice; Mouth Neoplasms; Nanoparticles; Neck | 2011 |
Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
Topics: Antibiotics, Antineoplastic; Bleomycin; Dose-Response Relationship, Drug; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Maxillary Neoplasms; Mouth Neoplasms; Sclerosing Solutions; Sclerotherapy; Treatment Outcome | 2011 |
Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Topics: Animals; Antibiotics, Antineoplastic; Antibody Specificity; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Fluorouracil; Humans; Hydrophobic and Hydrophilic Interactions; Immune Sera; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Protein Binding; Proteins; Recombinant Fusion Proteins | 2012 |
MEK inhibition enhances bleomycin A5-induced apoptosis in an oral cancer cell line: signaling mechanisms and therapeutic opportunities.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Cell Nucleus; Cell Survival; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; KB Cells; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mouth Neoplasms; Signal Transduction | 2004 |
[Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Topics: Antibiotics, Antineoplastic; Bleomycin; Carbon; Carcinoma, Squamous Cell; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Nanoparticles; Neck | 2004 |
[Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Collagen Type IV; Female; Humans; Immunoconjugates; Liver Neoplasms, Experimental; Mice; Molecular Weight; Mouth Neoplasms; Neoplasm Transplantation | 2006 |
Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Survival; DNA Fragmentation; Drug Synergism; Flow Cytometry; Humans; KB Cells; Mouth Neoplasms; Verapamil | 2007 |